Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Ripasudil (K-321) eye drops after cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema

Drugs mentioned

• Ripasudil (Ripasudil)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Corneal Edema After Cataract Surgery | Phase 3 | Status: COMPLETED